GALENAGEN
Galenagen, LLC
Application Filed: 2020-12-18
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90392963 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Nicole K. McLaughlin |
| Attorney Docket Number | U2400-00072 |
Timeline
| 2020-12-18 | Application Filed |
| 2020-12-22 | Location: NEW APPLICATION PROCESSING |
| 2020-12-22 | Status: Live/Pending |
| 2020-12-22 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Galenagen, LLC |
| Address | Suite S-528 800 Westchester Avenue Rye Brook DE 10573 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for the diagnosis, treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Antibacterial, antiviral and antifungal preparations for skin and wound healing; disinfectants and antiseptics; antimicrobial cleansers for sanitation purposes; Medical assays for testing of bodily fluids and tissues for testing of enzymes in humans; biological preparations for medical testing; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing; diagnostic biomarker reagents for medical testing; all the foregoing for the diagnosis and treatment of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-12-22 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-03-01 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-06-14 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-07-08 | 4 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-07-21 | 5 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-08-10 | 6 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-08-10 | 7 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-10-05 | 8 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-03-28 | 9 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2022-03-28 | 10 EXT1 S: |
| EXTENSION 1 GRANTED | 2022-03-28 | 11 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-03-30 | 12 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-09-30 | 13 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2022-09-30 | 14 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2022-09-30 | 15 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-10-04 | 16 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2023-03-29 | 17 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2023-03-29 | 18 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2023-03-29 | 19 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-03-31 | 20 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2023-10-02 | 21 EEXT I:Incoming Correspondence |
| SOU EXTENSION 4 FILED | 2023-10-02 | 22 EXT4 S: |
| SOU EXTENSION 4 GRANTED | 2023-10-02 | 23 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-10-04 | 24 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2024-04-02 | 25 EEXT I:Incoming Correspondence |
| SOU EXTENSION 5 FILED | 2024-04-02 | 26 EXT5 S: |
| SOU EXTENSION 5 GRANTED | 2024-04-02 | 27 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-04-03 | 28 EXRA E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 